Abstract
A novel library of chalcone linked thiazole-imidazopyridine (12a–j) derivatives were designed, synthesized, and their structures were characterized by 1H NMR, 13C NMR and mass spectral studies. Further, all compounds were tested for their anticancer effects on four human cancer cell lines including MCF-7 (breast carcinoma), A549 (lung carcinoma), DU-145 (prostate carcinoma) and MDA MB-231 (breast carcinoma) by employing MTT method, using etoposide as the positive control. Among them, compound 12b displayed more potent anticancer activity against four cancer cell lines when compared to the positive control.
Similar content being viewed by others
References
Agarwal M, Singh V, Sharma SC, Sharma P, Ansari MdY, Jadav SS, Yasmin S, Sreenivasulu R, Hassan MdH (2016) Design and synthesis of new 2,5-disubstituted 1,3,4-oxadiazole analogues as anticancer agents. Med Chem Res 25:2289–2303
Ahsan MJ, Choudhary K, Jadav SS, Yasmin S, Ansari MY, Sreenivasulu R (2015) Synthesis, antiproliferative activity and molecular docking studies of curcumin analogues bearing pyrazole ring. Med Chem Res 24:4166–4180
Al-Tel TH, Al-Qawasmeh RA, Zaarour R (2011) Design, synthesis and in vitro antimicrobial evaluation of novel imidazo[1,2-a]pyridine and imidazo[2,1-b][1,3]benzothiazole motifs. Eur J Med Chem 46:1874–1881
Bukowski L, Kaliszan R (1991) Imidazo[4,5-b]pyridine derivatives of potential tuberculostatic activity, II: synthesis and bioactivity of designed and some other 2-cyanomethylimidazo[4,5-b]pyridine derivatives. Arch Pharm 9:537–542
Byth KF, Geh C, Forder CL, Oakes SE, Thomas AP (2006) The cellular phenotype of AZ703, a novel selective imidazo[1,2-a]pyridine cyclin-dependent kinase inhibitor. Mol Cancer Ther 5:655–664
Cheenpracha S, Karalai C, Ponglimanont C, Subhadhirasakul S, Tewtrakul S (2006) Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata. Bioorg Med Chem 14:1710–1714
Clayton PE, Banerjee I, Murray PG, Renehan AG (2011) Growth hormone, the insulin-like-growth factor axis, insulin and cancer risk. Nat Rev Endocrinol 7:11–24
Clemens MR (1991) Free radicals in chemical carcinogenesis. KlinWochenschr 69:1123–1134
Dimmock JR, Kandepu NM, Hetherinqton M, Quail JW, Pugazhenthi U, Sudom AM, Chamankhah M, Rose P, Pass E, Allen TM, Halleran S, Szydlowski J, Mutus B, Tannous M, Manavathu EK, Myers TG, Clercq ED, Balzarini J (1998) Cytotoxic activities of mannich bases of chalcones and related compounds. J Med Chem 41:1014–1026
Ducki S, Forrest R, Hadfield JA, Kendall A, Lawerence NJ, McGrown AT, Rennison D (1998) Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure−activity relationship analysis. Bioorg Med Chem Lett 8:1051–1056
Durgesh R, Sreenivasulu R, Srinivasarao P, Raju RR (2018a) Synthesis and anti-tumor evaluation of novel 5-bromo indole-aryl ketohydrazide-hydrazone analogues. Asian J Chem 30:1201–1204
Durgesh R, Sreenivasulu R, Srinivasarao P, Raju RR (2018b) Synthesis and anticancer evaluation of indazole-aryl hydrazide-hydrazone derivatives. J Ind Chem Soc 95:433–438
Durgesh R, Sreenivasulu R, Raju RR (2018c) Synthesis and anti-tumor evaluation of Indole-substituted Indole fused keto hydrazide-hydrazones. J Pharm Res 12:42–46
ElHady AK, Abdel-Halim, Abadi MAH, Engel M (2017) Development of selective Clk1 and -4 inhibitors for cellular depletion of cancer-relevant proteins. J Med Chem 60:5377–5391
Fu Y, Hsieh TC, Guo J, Kunicki J, Lee MYWT, Darzynkiewicz Z, Wu JM (2004) Licochalcone-A, a novel flavonoid isolated from licorice root (Glycyrrhiza glabra), causes G2 and late-G1 arrests in androgen-independent PC-3 prostate cancer cells. Biochem Biophys Res Commun 322:263–270
Furman C, Lebeau J, Fruchart JC, Bernier JL, Duiez P, Cotelle N, Teissier E (2001) Di-tert-butylhydroxylated flavonoids protect endothelial cells against oxidized LDL-induced cytotoxicity. J Biochem Mol Toxicol 15:270–278
Go ML, Wu X, Liu XL (2005) Chalcones: an update on cytotoxic and chemo protective properties. Curr Med Chem 12:481–499
Gudmundsson KS, Williams JD, Drach JC, Townsend LB (2003) Synthesis and antiviral activity of novel erythrofuranosyl imidazo[1,2-a]pyridine C-nucleosides constructed via palladium coupling of iodoimidazo[1,2-a]pyridines and dihydrofuran. J Med Chem 46:1449–1455
Gueiffier A, Mavel S, Lhassani M, Elhakmaoui A, Snoeck R, Andrei G, Chavignon O, Teulade JC, Witvrouw M, Balzarini J, De Clercq E, Chapat JP (1998) Synthesis of imidazo[1,2-a]pyridines as antiviral agents. J Med Chem 41:5108–5112
Harrison TS, Keating GM (2005) Zolpidem: a review of its use in the management of insomnia. CNS Drugs 19:65–89
Hatti I, Sreenivasulu R, Jadav SS, Ahsan MJ, Raju RR (2015a) Synthesis and biological evaluation of 1,3,4-oxadiazole linked bis indole derivatives as anticancer agents. Monatsh Chem 146:1699–1705
Hatti I, Sreenivasulu R, Jadav SS, Jayaprakash V, Kumar CG, Raju RR (2015b) Synthesis, cytotoxic activity and docking studies of new 4 – aza podophyllotoxin derivatives. Med Chem Res 24:3305–3313. https://www.rcsb.org/5X8I
John R, Ross H (2010) The global economic cost of cancer. American Cancer Society, Atlanta
Kamal A, Kumar GB, Nayak VL, Reddy VS, Shaik AB, Rajender K, Reddy MK (2015) Design, synthesis and biological evaluation of imidazopyridine/imidazopyrimidine-benzimidazole conjugates as potential anticancer agents. Med Chem Commun 6:606–612
Kamal A, Reddy JS, Ramaiah MJ, Dastagiri D, Bharathi EV, Sagar MVP, Pushpavalli SNCVL, Ray P, Pal-Bhadra M (2010) Design, synthesis and biological evaluation of imidazopyridine/pyrimidine-chalcone derivatives as potential anticancer agents. Med Chem Commun 1:355–360
Kercher T, Rao C, Bencsik JR, Josey JA (2007) Diversification of the three-component coupling of 2-aminoheterocycles, aldehydes, and isonitriles: efficient parallel synthesis of a diverse and druglike library of imidazo- and tetrahydroimidazo[1.2-a]heterocycles. J Comb Chem 9:1177–1187
Lacerda RB, de Lima CK, da Silva LL, Romeiro NC, Miranda AL, Barreiro EJ, Fraga CA (2009) Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2a]pyridine symbiotic prototypes. Bioorg Med Chem 17:74–84
Lahtchev KL, Batovska DI, Parushev SP, Ubiyvovk VM, Sibirny AA (2008) Antifungal activity of chalcones: a mechanistic study using various yeast strains. Eur J Med Chem 43:2220–2228
Lancel M, Steiger A (1999) Sleep and its modulation by drugs that affect GABA, receptor function. Angew Chem Int Ed 38:2852–2864
Langer SZ, Arbilla S, Benavides J, Scatton B (1990) Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes. Adv Biochem Psychopharmacol 46:61–72
Larsen M, Kromannn H, Kharazmi A, Nielsen SF (2005) Conformationally restricted anti plasmodial chalcones. Bioorg Med Chem Lett 15:4858–4861
Liaras K, Geronikaki A, Glamoclija J, Ciric A, Sokovic M (2011) Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation. Bioorg Med Chem Lett 19:3135–3140
Lin YM, Zhou LM, Flavin MT, Nie W, Chen FC (2002) Chalcones and flavonoids as anti-tuberculosis agents. Bioorg Med Chem 10:2795–2802
Madhavi S, Sreenivasulu R, Ansari MdY, Ahsan MJ, Raju RR (2016) Synthesis, biological evaluation and molecular docking studies of pyridine incorporated chalcone derivatives as anticancer agents. Lett Org Chem 13:682–692
Madhavi S, Sreenivasulu R, Jyotsna Y, Raju RR (2017a) Synthesis of chalcone incorporated quinazoline derivatives as anticancer agents. Saudi Pharm J 25:275–279
Madhavi S, Sreenivasulu R, Raju RR (2017b) Synthesis and biological evaluation of oxadiazole incorporated ellipticine derivatives as anticancer agents. Monatsh Chem 148:933–938
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444
Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D (2003) NF-kappa B functions in synaptic signaling and behaviour. Nat Neurosci 6:1072–1078
Modzelewska A, Pettit C, Achanta G, Davidson NE, Huang P, Khan SR (2006) Anticancer activities of novel chalcone and bis-chalcone derivatives. Bioorg Med Chem 14:3491–3495
Murthy IS, Sreenivasulu R, Alluraiah G, Raju RR (2019) Design, synthesis and anticancer evaluation of 1,2,3-triazole linked 1,2-isoxazole - imidazo[4,5-b]pyridine derivatives. Russian J Gen Chem 89:1718–1723
Nielsen SF, Christensen SB, Cruciani G, Kharazmi A, Liljefors T (1998) Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure−activity relationship analysis. J Med Chem 41:4819–4832
Nowakowska Z (2007) A review of anti-infective and anti-inflammatory chalcones. Eur J Med Chem 42:125–137
Park SK, Cho LY, Yang JJ, Park B, Chang SH, Lee KS, Kim H, Yoo KY, Lee CT (2010) Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study. Lung Cancer 68:20–26
Porta C, Riboldi E, Sica A (2011) Mechanisms linking pathogens-associated inflammation and cancer. Cancer Lett 305:250–262
Pragathi YJ, Sreenivasulu R, Veronica D, Madhavi S, Raju RR (2019) Design, synthesis and biological evaluation of novel 2-(4-aryl-substituted-1H-1,2,3-triazol-1-yl)-N-(4-(2- (thiazol-2-yl)benzo[d]thiazol-6-yl)phenyl) acetamide derivatives as potent anticancer agents. Russian J Gen Chem 89:1009–1014
Rao BVD, Sreenivasulu R, Rao MVB (2019) Design, synthesis, and evaluation of isoxazole-thiadiazole linked carbazole hybrids as anticancer agents. Russian J Gen Chem 89:2115–2120
Reddy NB, Burra VR, Ravindranath LK, Kumar VN, Sreenivasulu R, Sadanandam P (2016a) Synthesis and biological evaluation of benzimidazole fused ellipticine derivatives as anticancer agents. Monatsh Chem 147:599–604
Reddy NB, Burra VR, Ravindranath LK, Sreenivasulu R, Kumar VN (2016b) Synthesis and biological evaluation of benzoxazole fused combretastatin derivatives as anticancer agents. Monatsh Chem 147:593–598
Reddy KT, Sreenivasulu R, Raju RR (2019) Synthesis and biological evaluation of 1,2,4-oxadiazole linked imidazopyrazine derivatives as anticancer agents. J Ind Chem Soc 96:1085–1090
Rival Y, Grassy G, Taudon A, Ecalle R (1991) Antifungal activity in vitro of some imidazo[1,2-a]pyrimidine derivatives Activité antifongique in vitro de quelques dérivés de l’imidazo[1,2-a]pyrimidine. Eur J Med Chem 26:13–18
Rojas J, Payá M, Domínguez JN, Ferrándiz ML (2003) ttCH, a selective inhibitor of inducible nitric oxide synthase expression with antiarthritic properties. Eur J Pharmacol 465:183–189
Rozmer Z, Perjési P (2016) Naturally occurring chalcones and their biological activities. Phytochem Rev 15:87–120
Satyanarayana M, Tiwari P, Tripathi BK, Srivastava AK, Pratap R (2004) Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines. Bioorg Med Chem 12:883–889
Shahinshavali S, Sreenivasulu R, Guttikonda VR, Kolli D, Rao MVB (2019) Synthesis and anticancer activity of amide derivatives of 1,2-isoxazole combined 1,2,4-thiadiazole. Russian J Gen Chem 89:324–329
Spandana Z, Sreenivasulu R, Rao MVB (2018a) Design, synthesis and anticancer evaluation of carbazole fused aminopyrimidine derivatives. Lett Org Chem 16:662–667
Spandana Z, Sreenivasulu R, Rekha TM, Rao MVB (2018b) Novel 1,3,4-oxadiazole fused thiadiazole derivatives: synthesis and study of anticancer activities. Lett Drug Des Discov 16:656–662
Sreenivasulu R, Durgesh R, Jadav SS, Sujitha P, Kumar CG, Raju RR(2018) Synthesis,anticancer evaluation and molecular docking studies of Bis(indolyl)triazinones, Nortopsentin analogues Chem Pap 72:1369–1378
Sreenivasulu R, Sujitha P, Jadav SS, Ahsan MJ, Kumar CG, Raju RR (2017) Synthesis, antitumor evaluation and molecular docking studies of Indole-Indazolyl hydrazide hydrazone derivatives. Monatsh Chem 148:305–314
Sreenivasulu R, Reddy KT, Jadav SS, Sujitha P, Kumar CG, Raju RR (2019) Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl) hydrazide-hydrazone derivatives. Bioorg Med Chem 27:1043–1055
Sreenivasulu R, Tej MB, Jadav SS, Sujitha P, Kumar CG, Raju RR (2020) Synthesis, anticancer evaluation and molecular docking studies of 2,5-bis(indolyl)-1,3,4-oxadiazoles, Nortopsentin analogues. J Mol Struct 1208:127875
Starrett JE, Montzka TA, Crosswell AR, Cavanagh RL (1989) Synthesis and biological activity of 3-substituted imidazo[1,2-a]pyridines as antiulcer agents. J Med Chem 32:2204–2210
Subramanyam M, Sreenivasulu R, Rambabu G, Rao MVB, Rao KP (2018) Synthesis, biological evaluation and docking studies of 1,3,4-oxadiazole fused benzothiazole derivatives for anticancer drugs. Lett Drug Des Discov 15:1299–1307
Suma VR, Sreenivasulu R, Subramanyam M, Rao KRM (2019) Design, synthesis and anticancer activity of amide derivatives of structurally modified combretastatin-A4. Russian J Gen Chem 89:499–504
Sun QZ, Lin GF, Li LL, Jin XT, Huang LY, Zhang G, Yang W, Chen X, Xiang R, Chen C, Wei YQ, Lu GW, Yang SY (2017) Discovery of potent and selective inhibitors of Cdc2-like kinase 1 (CLK1) as a new class of autophagy inducers. J Med Chem 60:6337–6352
Temple C (1990) Antimitotic agents. Synthesis of imidazo[4,5-c]pyridine-6-ylcarbamates and imidazo[4,5-b]pyridine-5-ylcarbamates. J Med Chem 33:656–661
ChoI HG, Son JB, Kim S, Lee S, Ko E, Cho J, Kang SY, Kim SY, Park JH, Ko YK, Ryu HY, Kim ND, Kim H, Lee Y, Lee SH, Kim D, Lee SJ, Hong S, Min SH, Lee S, Choi DK, Bae JH, Hong E, Jang T, Song J, Kim S, Yoon SK (2017) Novel imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer. WO2017222285A1
Yakantham T, Sreenivasulu R, Raju RR (2019) Design, synthesis and anticancer evaluation of 2-(3-(4-((5-aryl-1,2,4-oxadiazol-3-yl)methoxy)phenyl)isoxazol-5-yl)-N-(3,4,5-trimethyl phenyl)thiazol-4-amine derivatives. Russ J Gen Chem 89:1485–1490
Yoon G, Kang BY, Cheon SH (2007) Topoisomerase I inhibition and cytotoxicity of licochalcones A and E from Glycyrrhiza inflate. Arch Pharm Res 30:313–316
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Suma, V.R., Sreenivasulu, R., Rao, M.V.B. et al. Design, synthesis, and biological evaluation of chalcone-linked thiazole-imidazopyridine derivatives as anticancer agents. Med Chem Res 29, 1643–1654 (2020). https://doi.org/10.1007/s00044-020-02590-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-020-02590-9